Showing results (2891-2900 of 3,090) with videos related to
Sort By:
Pageof 309
Drug Safety|September 20, 2013
Post-approval safety issues with innovative drugs: a European cohort studyPeter G M Mol, Arna H Arnardottir, Domenico Motola, et al.Drug Safety|May 16, 2013
Illustration of the weibull shape parameter signal detection tool using electronic healthcare record dataOdile Sauzet, Alfonso Carvajal, Antonio Escudero, et al.Drug Safety|June 18, 2013
Traceability of biopharmaceuticals in spontaneous reporting systems: a cross-sectional study in the FDA Adverse Event Reporting System (FAERS) and EudraVigilance databasesNiels S Vermeer, Sabine M J M Straus, Aukje K Mantel-Teeuwisse, et al.Drug Safety|June 19, 2013
Profile of sexual and genitourinary treatment-emergent adverse events associated with atomoxetine treatment: a pooled analysisAngelo Camporeale, Kathleen Ann Day, Dustin Ruff, et al.Drug Safety|March 20, 2013
Incidence of adverse events among healthcare workers following H1N1 Mass immunization in Ghana: a prospective studyDaniel N A Ankrah, Aukje K Mantel-Teeuwisse, Marie L De Bruin, et al.Drug Safety|April 13, 2013
Ischaemic colitis in rheumatoid arthritis patients receiving tumour necrosis factor-α inhibitors: an analysis of reports to the US FDA Adverse Event Reporting SystemAllison Salk, Derrick J Stobaugh, Parakkal Deepak, et al.Drug Safety|February 23, 2013
Intentional rechallenge: does the benefit outweigh the risk?Vid Stanulović, Mauro Venegoni, Brian EdwardsDrug Safety|May 10, 2013
The impact of direct healthcare professional communication on prescribing practice in the UK hospital setting: an interrupted time series analysisSarah K Thomas, James Hodson, Graham McIlroy, et al.Drug Safety|April 27, 2013
Tyrosine kinase inhibitors: their on-target toxicities as potential indicators of efficacyDevron R Shah, Rashmi R Shah, Joel MorganrothPageof 309